Transparency Market Research
Healthcare Contract Research Outsourcing Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 – 2018 Single User License: US $ 4595
Buy Now Request Sample
Published Date: Jan 2013
94 Pages Report
Multi User License: US $ 7595 Corporate User License: US $ 10595
REPORT DESCRIPTION Healthcare Contract Research Outsourcing Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 – 2018 This report covers the market revenue for the global healthcare contract research outsourcing market. A detailed analysis of the market trends, current scenarios and future trends is available in the report. The market is analyzed by using concepts such as market dynamics including drivers, restraints and opportunities along with their impact analyses trend analysis, and market attractiveness analysis. The market is segmented on the basis of services offered into: Clinical trials, regulatory services, medical writing services, clinical data management services. A detailed trend analysis of all the segments with a market evaluation in terms of revenue generated with respect to the applications and geography is available in this report. The market is
Browse Report: Healthcare Contract Research Outsourcing Market segmented on the basis of the outsourcing destination research groups including Contract Research Organizations (CROs), Clinical Trial Laboratories (CTL), and Academic Medical Centers (AMCs) The report also segments healthcare contract research outsourcing market based on geography into: North America, Europe, Asia and the rest of the world. A competitive analysis of the market players involved is covered in the report. Some of the major players of this market include: Quintiles, Covance, PPD, Parexel, CRL, Icon, Plc. Medidata Solutions, InVentiv Health, Theorem Clinical research and others. Company overview, financial overview, business strategies, SWOT analysis, recent developments and product portfolio for each of the market player is also highlighted in the report. The study presents a comprehensive assessment of the stakeholder strategies and winning imperatives for them by segmenting the Contract research outsourcing market as below:
Global healthcare contract research outsourcing market by services
Clinical trial services Drug discovery Preclinical studies
Phase IV trial (Post marketing surveillance) services
Regulatory services Medical writing services Clinical data management (CDM) services Regulatory services Medical writing services Clinical data management (CDM) services
Global healthcare contract research outsourcing market by destination research groups
Contract Research Organizations (CROs) Clinical Trial Laboratories Academic Medical Centers (AMCs)
Global healthcare contract research outsourcing market by Geography
North America Europe Asia RoW
TABLE OF CONTENTS CHAPTER 1 PREFACE 1.1 REPORT DESCRIPTION 1.2 RESEARCH METHODOLOGY
CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET ANALYSIS 3.1 OVERVIEW 3.2 MARKET DRIVERS 3.2.1 INCREASING COST AND REDUCING PRODUCTIVITY 3.2.2 PATENT EXPIRATIONS 3.2.3 DECREASING NEW DRUGS RESEARCH AND DEVELOPMENT (R&D) 3.2.4 EMERGENCE OF BIOLOGICAL THERAPIES AS THE NEXT GENERATION TREATMENT OPTION 3.2.5 GLOBALIZATION OF DRUG DEVELOPMENT PROCESS 3.3 MARKET RESTRAINTS 3.3.1 VARIATION IN REGULATORY GUIDELINES AND APPROVAL PROCESS IN DIFFERENT COUNTRIES 3.3.2 QUALITY ISSUES 3.3.3 GENETIC AND DISEASE PROFILE VARIATIONS 3.3.4 UNFORESEEN COSTS 3.3.5 DATA CONFIDENTIALITY ISSUES 3.3.6 RELIABILITY AND SERVICE OUTAGES 3.4 MARKET OPPORTUNITIES 3.4.1 INCREASING CLINICAL TRIALS IN EMERGING COUNTRIES 3.4.2 INCREASING OUTSOURCING OF REGULATORY, CLINICAL DATA MANAGEMENT AND MEDICAL WRITING ACTIVITIES Browse Rport: http://www.transparencymarketresearch.com/hcro-market.html
CHAPTER 4 GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY SERVICES 4.1 OVERVIEW 4.2 CLINICAL TRIAL SERVICES 4.2.1 DRUG DISCOVERY SERVICES 4.2.2 PRECLINICAL SERVICES 4.2.3 PHASE I TRIAL SERVICES 4.2.4 PHASE II TRIAL SERVICES 4.2.5 PHASE III TRIAL SERVICES 4.2.6 PHASE IV TRIAL (POST MARKETING SURVEILLANCE) SERVICES 4.3 REGULATORY SERVICES 4.4 MEDICAL WRITING SERVICES 4.5 CLINICAL DATA MANAGEMENT (CDM) SERVICES 4.6 OTHERS
CHAPTER 5 GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING, BY DESTINATION RESEARCH GROUPS 5.1 OVERVIEW 5.2 CONTRACT RESEARCH ORGANIZATIONS (CROS) 5.2.1 GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET REVENUE, BY SERVICES, 2010-2018 (USD BILLION) 5.3 CLINICAL TRIAL LABORATORIES (CTL) 5.3.1 GLOBAL CLINICAL TRIAL LABORATORIES OUTSOURCING MARKET REVENUE, BY SERVICES, 2010-2018 (USD BILLION) 5.4 ACADEMIC MEDICAL CENTERS (AMCS) 5.4.1 GLOBAL ACADEMIC MEDICAL CENTERS OUTSOURCING MARKET REVENUE, BY SERVICES, 2010-2018 (USD BILLION)
Browse Rport: http://www.transparencymarketresearch.com/hcro-market.html
CHAPTER 6 GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY GEOGRAPHY 6.1 OVERVIEW 6.2 NORTH AMERICA 6.2.1 HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY DESTINATION RESEARCH GROUPS 2010- 2018 (USD BILLION) 6.2.2 HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY SERVICES 2010- 2018 (USD BILLION) 6.2.3 CLINICAL TRIAL OUTSOURCING MARKET, BY CLINICAL TRIALS 2010- 2018 (USD BILLION) 6.3 EUROPE 6.3.1 HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY DESTINATION RESEARCH GROUPS 2010- 2018 (USD BILLION) 6.3.2 HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY SERVICES 2010- 2018 (USD BILLION) 6.3.3 CLINICAL TRIAL OUTSOURCING MARKET, BY CLINICAL TRIALS 2010- 2018 (USD BILLION) 6.4 ASIA 6.4.1 HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY DESTINATION RESEARCH GROUPS 2010- 2018 (USD BILLION) 6.4.2 HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY SERVICES 2010- 2018 (USD BILLION) 6.4.3 CLINICAL TRIAL OUTSOURCING MARKET, BY CLINICAL TRIALS 2010- 2018 (USD BILLION) 6.5 REST OF WORLD 6.5.1 HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY DESTINATION RESEARCH GROUPS 2010- 2018 (USD BILLION) 6.5.2 HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY SERVICES 2010- 2018 (USD BILLION) 6.5.3 CLINICAL TRIAL OUTSOURCING MARKET, BY CLINICAL TRIALS 2010- 2018 (USD BILLION) Browse Rport: http://www.transparencymarketresearch.com/hcro-market.html
CHAPTER 7 COMPETITIVE LANDSCAPE 7.1 OVERVIEW 7.2 MARKET SHARE BY KEY PLAYERS 7.3 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS 7.3.1 EXPANDING RESEARCH SERVICE CAPABILITIES 7.3.2 COST EFFECTIVE BUSINESS MODELS 7.3.3 ABSORBING SKILLED RESEARCH PERSONNEL
CHAPTER 8 RECOMMENDATIONS 8.1 MARKET STRATEGY FOR SUCCESS 8.2 BARRIERS TO BE CONSIDERED
CHAPTER 9 COMPANY PROFILES 9.1 QUINTILES TRANSNATIONAL CORPORATION 9.1.1 COMPANY OVERVIEW 9.1.2 FINANCIAL INFORMATION 9.1.3 BUSINESS STRATEGIES 9.1.3.1 Expansion of services 9.1.3.2 Acquisitions and partnerships 9.1.3.3 Innovation in services offered 9.1.4 PRODUCT PORTFOLIO 9.1.5 RECENT DEVELOPMENTS 9.2 COVANCE, INC. 9.2.1 OVERVIEW 9.2.2 FINANCIAL INFORMATION 9.2.3 BUSINESS STRATEGIES
9.2.3.1 New product development and innovation 9.2.3.2 Agreements and collaborations 9.2.4 PRODUCT PORTFOLIO 9.2.5 RECENT DEVELOPMENTS 9.3 PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPD) 9.3.1 COMPANY OVERVIEW 9.3.2 FINANCIAL INFORMATION 9.3.3 BUSINESS STRATEGIES 9.3.3.1 New product launch and innovation 9.3.3.2 Expanding geographic presence 9.3.4 PRODUCT PORTFOLIO 9.3.5 RECENT DEVELOPMENTS 9.4 PAREXEL INTERNATIONAL CORPORATION 9.4.1 COMPANY OVERVIEW 9.4.2 FINANCIAL INFORMATION 9.4.3 BUSINESS STRATEGIES 9.4.3.1 Strong presence in Asia and emerging markets 9.4.3.2 Strategic alliances 9.4.4 PRODUCT PORTFOLIO 9.4.5 RECENT DEVELOPMENTS 9.5 CHARLES RIVER LABORATORIES INTERNATIONAL INC. (CRL) 9.5.1 COMPANY OVERVIEW 9.5.2 FINANCIAL INFORMATION 9.5.3 BUSINESS STRATEGIES 9.5.3.1 Business expansion in APAC region 9.5.3.2 Expansion of services offered 9.5.3.3 New product launches and Innovation;
9.5.4 PRODUCT PORTFOLIO 9.5.5 RECENT DEVELOPMENTS 9.6 ICON, PLC 9.6.1 COMPANY OVERVIEW 9.6.2 FINANCIAL INFORMATION 9.6.3 BUSINESS STRATEGY 9.6.3.1 Business expansion in APAC region 9.6.3.2 Expansion of services offered 9.6.3.3 New product launches and Innovation 9.6.4 PRODUCT PORTFOLIO 9.6.5 RECENT DEVELOPMENTS 9.7 MEDIDATA SOLUTIONS, INC. 9.7.1 COMPANY OVERVIEW 9.7.2 FINANCIAL INFORMATION 9.7.3 BUSINESS STRATEGY 9.7.3.1 New product launches and Innovation 9.7.3.2 Focus on emerging economies 9.7.3.3 Well defined services and initiatives 9.7.4 PRODUCT PORTFOLIO 9.7.5 RECENT DEVELOPMENTS 9.8 INVENTIV HEALTH, INC. (PHARMANET DEVELOPMENT GROUP INC.) 9.8.1 COMPANY OVERVIEW 9.8.2 BUSINESS STRATEGY 9.8.2.1 Expansion through agreements and acquisitions 9.8.2.2 Rebranding subsidiaries 9.8.3 PRODUCT PORTFOLIO 9.8.4 RECENT DEVELOPMENTS
9.9 PIRAMAL LIFE SCIENCES 9.9.1 COMPANY OVERVIEW 9.9.2 FINANCIAL INFORMATION 9.9.3 BUSINESS STRATEGY 9.9.3.1 Expansion of services offered 9.9.4 PRODUCT PORTFOLIO 9.9.5 RECENT DEVELOPMENTS About Us: Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/